LAM
NVRO

Lebenthal Asset Management’s NEVRO CORP. NVRO Stock Holding History

Lebenthal Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-365
Closed -$38K – 717
2016
Q3 		$38K Buy
+365
New +$33K ﹤0.01% 471

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Lebenthal Asset Management's NVRO Position: Q4 2016 in Review

Lebenthal Asset Management sold out of NEVRO CORP. (NVRO) in Q4 2016, closing a stake of 365 shares — an estimated $38K sold.

Lebenthal Asset Management first reported a position in NVRO in Q3 2016 and held it in 1 quarter. The position peaked at $38K in Q3 2016. 174 funds tracked by Wall St. Rank hold NVRO as of Q4 2016.

  • Lebenthal Asset Management reported no remaining NEVRO CORP. position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 365 NEVRO CORP. shares in Q4 2016, an estimated $38K.
  • Lebenthal Asset Management first reported a position in NEVRO CORP. in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's NEVRO CORP. position peaked at $38K in Q3 2016.
  • 174 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.